This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Chemical Company, Limited. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: Inventor Tatsuo Kanda: Pioneering Sulfonylamide Production
Introduction
Tatsuo Kanda is a notable inventor based in Toyonaka, Japan. With a focused background in chemistry, he holds a significant patent that contributes to the field of sulfonamide derivatives, demonstrating innovation in pharmaceutical chemistry.
Latest Patents
Kanda's sole patent involves a "Process for producing sulfonylamides," specifically highlighting the sulfonylamide derivatives of a particular formula. This invention aims to enhance the efficiency and effectiveness of producing sulfonamide compounds, which are fundamental in various medicinal applications.
Career Highlights
Tatsuo Kanda is associated with Sumitomo Chemical Company, Limited, where he applies his expertise in chemistry to further research and development. His contributions to the company underscore his role as an innovator in the chemical industry, reflecting his capability to improve product offerings and drive scientific advancements.
Collaborations
During his career, Kanda has collaborated with distinguished coworkers, including Hideaki Suda and Hiroshige Tomita. These partnerships exemplify a team-oriented approach to innovation, as they work together to explore new possibilities in chemical engineering.
Conclusion
In conclusion, Tatsuo Kanda’s work on sulfonylamide production not only highlights his unique contributions as an inventor but also emphasizes the importance of collaboration in advancing scientific knowledge. His efforts at Sumitomo Chemical Company continue to pave the way for future innovations in the field of chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile